Technical Analysis for NVS - Novartis AG

Grade Last Price % Change Price Change
grade A 93.42 -0.31% -0.29
NVS closed down 0.31 percent on Friday, March 22, 2019, on 1.41 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical NVS trend table...

Date Alert Name Type % Chg
Mar 22 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 22 Overbought Stochastic Strength 0.00%
Mar 21 New 52 Week Closing High Bullish -0.31%
Mar 21 Pocket Pivot Bullish Swing Setup -0.31%
Mar 21 NR7 Range Contraction -0.31%
Mar 21 Upper Bollinger Band Walk Strength -0.31%
Mar 21 Inside Day Range Contraction -0.31%
Mar 21 Overbought Stochastic Strength -0.31%
Mar 20 New 52 Week Closing High Bullish -0.06%
Mar 20 New 52 Week High Strength -0.06%

Older signals for NVS ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Novartis AG engages in the research, development, manufacture, and marketing of a range of healthcare products worldwide. Its Pharmaceuticals division offers patented prescription medicines in various therapeutic areas, including oncology; primary care and established medicines; specialty care, such as ophthalmology, neuroscience, integrated hospital care, and critical care; and cardiovascular and metabolism, respiratory, and other medicines. The company's Alcon division provides various eye care products, including ophthalmic surgical equipment, instruments, disposable products, and intraocular lenses; medicines to treat chronic and acute diseases of the eye; over-the-counter medicines for the eye; and contact lenses and lens care products. Its Sandoz division offers prescription medicines, as well as pharmaceutical and biotechnological active substances. This division provides active ingredients and finished dosage forms of pharmaceuticals; active pharmaceutical ingredients and intermediates, primarily antibiotics; protein or biotechnology-based products; cytotoxic products for the hospital market; and biotech manufacturing services to other companies. The company's Vaccines and Diagnostics division provides preventive human vaccines, and blood testing and molecular diagnostics products to prevent the spread of infectious diseases. Its Consumer Health division consists of two divisions, including over-the-counter medicines that offer readily available consumer medicines; and Animal Health, which provides veterinary products for farm and companion animals. Novartis AG was founded in 1895 and is headquartered in Basel, Switzerland.
Health Biotechnology Pharmaceutical Industry Pharmaceuticals Drugs Infectious Diseases Medication Pharmacy Pharmaceutical Industry In China Pharmaceuticals Policy Neuroscience Active Pharmaceutical Ingredients Antibiotics Healthcare Products Over The Counter Drug Prescription Drug Veterinary Products
Is NVS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 93.89
52 Week Low 72.3
Average Volume 1,981,675
200-Day Moving Average 85.0246
50-Day Moving Average 89.533
20-Day Moving Average 91.42
10-Day Moving Average 92.385
Average True Range 0.913
ADX 24.31
+DI 35.2969
-DI 14.6433
Chandelier Exit (Long, 3 ATRs ) 91.151
Chandelier Exit (Short, 3 ATRs ) 91.489
Upper Bollinger Band 94.3727
Lower Bollinger Band 88.4673
Percent B (%b) 0.84
BandWidth 6.459637
MACD Line 1.1473
MACD Signal Line 0.9331
MACD Histogram 0.2143
Fundamentals Value
Market Cap 218.88 Billion
Num Shares 2.34 Billion
EPS 2.74
Price-to-Earnings (P/E) Ratio 34.09
Price-to-Sales 3.85
Price-to-Book 2.71
PEG Ratio 2.69
Dividend 2.72
Dividend Yield 2.91%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 94.25
Resistance 3 (R3) 94.28 94.03 94.11
Resistance 2 (R2) 94.03 93.82 94.02 94.06
Resistance 1 (R1) 93.73 93.69 93.88 93.70 94.02
Pivot Point 93.48 93.48 93.56 93.47 93.48
Support 1 (S1) 93.18 93.27 93.33 93.15 92.82
Support 2 (S2) 92.93 93.14 92.92 92.78
Support 3 (S3) 92.63 92.93 92.73
Support 4 (S4) 92.60